Medical Technology

@xconomy.com 4 years ago

CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019

@xconomy.com 4 years ago

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More

@xconomy.com 5 years ago

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

@xconomy.com 5 years ago

CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells

@xconomy.com 5 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

@xconomy.com 5 years ago

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M

@techcrunch.com 7 years ago

CRISPR loses Nobel to tiny machines

@techcrunch.com 7 years ago

Reshaping human health and changing lives through gene editing